Chairs: Dr Jacobo Sellares Torres (Barcelona, Spain), Dr Florence Jeny (Bobigny, France)
Speakers: Dr Marcel Veltkamp (De Meern, Netherlands), Dr Vasileios Kouranos (London, United Kingdom), Dr Katharina Buschulte (Heidelberg, Germany)

Fees: Free for ERS members / €10 for non-members
Find out more about becoming a member

Overview

In recent years, guidelines and statements on diagnosis and treatment of both pulmonary and cardiac sarcoidosis have been published. However, in daily practice the treating physician has to deal with uncertainty regarding which drug to use, dosage, duration of treatment and assessment of relapse risk. Furthermore, regarding cardiac sarcoidosis, there are recent conflicting statements regarding screening.

Educational aims

• Provide a hands-on overview of the latest studies on treatment of pulmonary and cardiac sarcoidosis as well as screening algorithm for cardiac sarcoidosis.

Topics:

1. Treatment of pulmonary sarcoidosis

• Prednisone vs MTX as first line treatment options including different doses
• Duration of therapy and assessment of inflammatory activity
• Tapering of medication and risk of relapse

2. Screening for cardiac sarcoidosis

• Appreciate the central role of MRI and FDG-PET in assessment of cardiac sarcoidosis
• Appreciate the role of ECG, holter monitoring en echocardiography in screening for CS

3. Treatment of cardiac sarcoidosis

• Risk assessment of cardiac sarcoidosis
• Immunosuppressive therapies, decision-making regarding ICD and heart failure medication

Format

One-hour webinar format: 45 minutes for presentations, followed by a 15-minute Q&A session.

Learning outcomes

Following this webinar, participants will be able to:

• Make a treatment plan for patients with pulmonary sarcoidosis
• Learn how to use the most evidence based screening trajectory regarding cardiac sarcoidosis in patients they see with sarcoidosis in clinic.
• Appreciate the importance of an MDT including cardiologists and nuclear physician

CME credit

An application for accreditation of this webinar has been made to the European Board for Accreditation in Pneumology (EBAP) for 1 CME credit per 1-hour attendance. If accredited, the CME credit will be granted upon attendance of at least 60 minutes during the live webinar only.

What is a webinar?

A webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting. During the webinar, you will be asked to share your opinion on issues related to the topic using interactive polls.

All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.

Login guidelines

More information will be communicated in due course.

• Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact e-learning@ersnet.org.
• Check Central European Time.
• To achieve the best quality, we recommend to avoid downloading anything from the internet during your connection to the lecture and stopping all other programmes.
• Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.